Continuity of antidepressant treatment for adults with depression in the United States
Abstract
OBJECTIVE: Continuation of antidepressant treatment for depression beyond the first months helps to consolidate treatment response and to reduce the risk of early relapse. The authors sought to characterize the rate and pattern of antidepressant discontinuation among adults initiating antidepressant treatment for depression. METHOD: Data were drawn from the household component of the Medical Expenditure Panel Survey for 1996-2001. Analysis was limited to data for adults age 18 years and older (N=829) who initiated antidepressant treatment for depression and who 1) discontinued treatment during the first 30 days of treatment, 2) completed the first 30 days of treatment and then discontinued treatment during the following 60 days, or 3) continued treatment for more than 90 days after treatment initiation. RESULTS: A majority of the patients discontinued antidepressant therapy during the first 30 days (42.4%). Only 27.6% of the patients continued antidepressant therapy for more than 90 days. Antidepressant discontinuation during the first 30 days of treatment was significantly more common among Hispanics (53.8%) than non-Hispanics (41.3%); patients with fewer than 12 years of education (50.8%), compared with those with 12 or more years (39.3%); and patients with low family incomes (50.2%), compared with those with medium or high family incomes (38.6%). Patients were significantly more likely to continue antidepressant treatment beyond 30 days if they received psychotherapy (68.0% versus 43.7%), completed 12 or more years of education (64.8% versus 52.0%), or had private health insurance (60.1% versus 50.8%). Among those who continued antidepressants beyond 30 days, antidepressant continuity during the subsequent 60 days was significantly associated with fair or poor pretreatment self-rated mental health and physical health, treatment with a selective serotonin reuptake inhibitor or serotonin-norepinephrine reuptake inhibitor, and psychotherapy. CONCLUSIONS: Early discontinuation of antidepressant therapy is widespread in the community treatment of depression, especially among socioeconomically disadvantaged patients. Provision of psychotherapy and selection of an appropriate antidepressant medication may reduce the risk of discontinuation during the first 3 months of antidepressant treatment for depression.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The adherence rate with mADM in this study seems to be rather high compared with some other studies.
“On the other hand, possibly as a consequence of our optimisation of mADM in the control condition, the adherence rate with mADM seems to be rather high compared with some other studies (Bockting et al., 2008;Kuyken et al., 2008;Olfson et al., 2006).”
From Adding mindfulness-based cognitive therapy to maintenance antidepressant medication for prevention of relapse/recurrence in major depressive disorder: Randomised controlled trial (2015) · cites this paper as Olfson et al., 2006
The citation lists haven’t been fetched yet
References 30 · Cited by 392
- Authors
- Olfson, M., Marcus, S. C., Tedeschi, M., & Wan, G. J.
- Affiliations
- New York State Psychiatric Institute (US)
- Venue
- American Journal of Psychiatry
- Published
- 2006-01-01
- Volume
- 163
- Issue
- 1
- Pages
- 101-108
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2149939128
- Semantic Scholar
- 15f80ffbf33ce26cc37b4a6f073343c2fc8f1502
- Cited by
- 392
- References
- 30
- Citations by year
- 2026: 10 · 2025: 8 · 2024: 14 · 2023: 16 · 2022: 16 · 2021: 10 · 2020: 18 · 2019: 10 · 2018: 17 · 2017: 26 · 2016: 20 · 2015: 25 · 2014: 23 · 2013: 26 · 2012: 21
- FWCI
- 27.54
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Psychology › Social Psychology › Mental Health Treatment and Access
- Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Keywords
- antidepressant discontinuation, depression, early recurrence, psychotherapy, selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, socioeconomic disparities, Hispanic patients, health insurance, educational attainment, household income, self-rated mental health, community-based treatment
- MeSH terms
- Adolescent, Adult, Age Factors, Aged, Antidepressive Agents, Continuity of Patient Care, Depressive Disorder, Female, Health Services Research, Hispanic or Latino, Humans, Male, Middle Aged, Patient Dropouts, Psychiatric Status Rating Scales, Psychotherapy, Social Class, United States, Episode of Care, White People, Secondary Prevention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review